Nodexus Inc.
USPTO PatentsView assignee record - 5 granted patents across 3 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).
The verdict
According to USPTO PatentsView, Nodexus ranks #49,151 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 3 technology areas.
- #49,151
- of 49,997 US assignees by volume
- Top 27%
- by Innovation Score (43.8/100)
- 19.2
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R49151 · US Corporation #49,151 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #49,151/49,997
- PHOTO-FINISH No-bull Enterprises
- CPC-NARROW B01L · 3 areas
- INNOV-PAR 43.8/100
- CLAIMS-RICH 19.2 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2023–2025 · 3y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: No-bull Enterprises LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Nodexus’s 43.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Nodexus
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Nodexus · this assignee
Nodexus · this assignee
44 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Nodexus's Innovation Score is 43.8/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Nodexus?
Each dot is one of Nodexus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nodexus’s own 19.2 claims/patent is ABOVE the 17.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Nodexus's grants concentrate
Nodexus Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). By volume, Nodexus sits between No-bull Enterprises LLC and Noporvis Co., Ltd..
Nodexus's three-year grant acceleration
Nodexus Inc. shows 4 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Nodexus's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- No-bull Enterpris…
No-bull Enterprises LLC
5 patents
- Noah Medical
Noah Medical Corporation
5 patents
- Noble Sensors
Noble Sensors, LLC
5 patents
- Nobotgames
Nobotgames, Inc.
5 patents
- Noha
Noha, LLC
5 patents
- Nok9 AB
Nok9 AB
5 patents
- Noogen
Noogen LLC
5 patents
- Noporvis
Noporvis Co., Ltd.
5 patents
- Nodexus ◀
Nodexus Inc.
5 patents
What this shows Nodexus holds 5 patents at rank #49,055, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Nodexus
By rank, the assignees closest to #49,055 in granted patent volume.
Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)
Other assignees with the most granted patents in Nodexus's primary technology class.
- The Regents of the University of California 239 in class
- Illumina, Inc. 232 in class
- Becton, Dickinson and Company 193 in class
- Bio-Rad Laboratories, Inc. 174 in class
- President and Fellows of Harvard College 165 in class
- Life Technologies Corporation 158 in class
- Roche Diagnostics Operations, Inc. 141 in class
- Siemens Healthcare Diagnostics Inc. 119 in class
Nodexus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 27% higher than 73% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 4 | 80.0% |
| 2025partial year | 1 | 20.0% |
Which technologies does Nodexus Inc. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Nodexus Inc.'s patent record in context - here's where to go next.
- Nodexus Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 100% of its portfolio - see every assignee active in that class. Explore B01L
- Ranked #49,151 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Nodexus Inc. against No-bull Enterprises LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 43.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.